SCHEMBL13265840

SCHEMBL13265840

O=[N+]([O-])c1ccc(Sc2cccc(S(=O)(=O)Nc3ccc(Cl)nc3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM1A O60341 1/20 0.44
▸ MAOA P21397 1/20 0.44
▸ CA2 P00918 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ PGR P06401 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ AR P10275 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CRHBP P24387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13265839 0.88 KMT2A (0.49) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265926 0.84 CA2 (0.51) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265868 0.83 KMT2A (0.64) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265865 0.81 ALDH1A1 (0.70) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265923 0.81 KMT2A (0.56) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265922 0.80 ABL1 (0.49) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265921 0.79 PLAU (0.56) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265931 0.78 HTR6 (0.53) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265927 0.78 ALDH1A1 (0.55) KMT2AMEN1ALDH1A1CA2CA12
SCHEMBL13265929 0.78 MEN1 (0.62) KMT2AMEN1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754773-B2 Composition and synthesis of new reagents for inhibition of HIV replication UNIVERSITY OF MASSACHUSETTS (US) 2010-07-13 — — US disclosed
US-20070099919-A1 Composition and synthesis of new reagents for inhibition of HIV replication NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099919-A1 Composition and synthesis of new reagents for inhibition of HIV replication REV1, MAVS, ISG15 KMT2A 1930/4885MEN1 3658/4885ALDH1A1 4359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback